News & Events

Check out our news section to keep up to date with any upcoming events which we will be attending as well as any exciting news within the pharmaceutical industry.

Symbiosis to attend CPhI

Symbiosis will be returning for the third consecutive year to exhibit at the CPhI conference to promote our world class sterile manufacturing capabilities with support from our friends from Scottish Development International. The event held at Nord Villepinte, Paris, France, from the 7th to 9th October is one of the world’s leading pharmaceutical events. It provides an exciting opportunity for Symbiosis to… Read More

Symbiosis’ BIO 2014 Experience

For the Symbiosis team attending BIO 2014, the conference started in true BIO style with a spectacular welcome reception on the deck of the USS Midway Museum (below), involving great networking, good food, some lively entertainment, and a dash of maritime education. The evening came to an end as the San Diego bay shoreline was lit up by a BIO fireworks display… Read More

Symbiosis to attend Biotech Outsourcing Strategies cmc

Symbiosis, a leading cGMP manufacturer of sterile pharmaceuticals for clinical trials, is looking forward to attending a key event in the drug development outsourcing calendar later this month.  We will be attending Biotech Outsourcing Strategies (BOS) cmc on the 12th June in Copenhagen, Denmark.With a programme including small molecule and biologics tracks and a strong emphasis on virtual drug development, BOS cmc has… Read More

Pharmaceutical Breakthrough

Pharmaceutical and biotech companies have made huge advances recently in the fight against cancer. The Daily Mail has published a heart-warming article highlighting the huge effect that a new class of drugs called Antibody Drug Conjugates (ADCs) drugs can have on people. http://www.dailymail.co.uk/health/article-2567455/Cancer-patients-lethal-70-tumours-disappear-just-two-WEEKS-thanks-pioneering-treatment.htmlA British man suffering from a rare form of lymphoma was given only weeks to live after scans showed that… Read More

The Huge Potential of Antibody – Drug Conjugates

Symbiosis Pharmaceutical Services recently attended the World ADC conference in Frankfurt.  There, we were pleased to see 250 attendees from all over the world sharing ideas and reporting their experiences on the progress of ADC development. In combination with the event, World ADC published an insightful market research report  which is available for download by clicking the following link:-http://adcsummit-europe.com/uploads/ffiles/2014/01/659869.pdf.  This article illustrates… Read More

Insight into RABs Cabinets

RABS’ cabinets or Restricted Access Barrier Systems on a vertical Laminar Airflow cabinet are widely used in aseptic processing. These systems offer a flexible way of working over sanitised isolators and they negate the need for the use of sanitising agents such as hydrogen peroxide that may adverse impact the product or monitoring process. When working within a RABS, manual operations are… Read More

QP for GMP ASAP?

Recent reports in the media (http://www.in-pharmatechnologist.com/Regulatory-Safety/A-QP-for-GMP-That-is-the-suggestion-IRCA-launches-pharma-auditor-training) are suggesting that GMP auditors should have an equivalent professional qualification similar to that of a QP.  At Symbiosis, we asked our QA department what they think about this idea.  Murray McKay, QA director at Symbiosis with over 25 yrs experience said “This idea is not a new one.  I can see that a certain level… Read More

Symbiosis gains Approval for French Tax Credit

Recently Symbiosis Pharmaceutical Services applied for a CIR (Crédit d’Impôt de Recherche) tax accreditation from the Minister of higher Education and research in France for R&D work on behalf of French companies. Our request was favourably accepted and we are now approved until 2016.The CIR tax accreditation has provided Symbiosis with a strong basis to working with French companies and allows eligible… Read More

Get In Touch.


By ticking the box and clicking “Submit” below, you consent to receiving thought leadership, industry news, and invitations by email or other electronic means, which Symbiosis Pharmaceutical Services believes may be of value to you, relevant to your work and tailored to your professional profile and interests. This may include promotional information on products, services and events provided or organised by Symbiosis Pharmaceutical Services. By clicking the "Submit” button, you confirm that the information you have provided above is correct, and you agree to Symbiosis' processing of your personal data, including its transfer internationally and to third parties, in accordance with it's privacy policy.